PHARMACEUTICAL COMPOSITION CONTAINING HYDROXAMIC ACID DERIVATIVE AND ANTITUMOR AGENTS WITH IMPROVED ANTITUMOR ACTIVITY AND / OR REDUCED SIDE EFFECTS

摘要

Pharmaceutical compositions that exhibit reduced gastrointestinal side-effects comprising a known active substance having antitumor effects selected from the group consisting of pyrimidine derivatives, or a pharmaceutically acceptable acid addition salt thereof, and O-(3-piperidino-2-hydroxy-1-propyl)nicotinic acid amidoxime, or a pharmaceutically acceptable acid addition salt thereof, are disclosed.